UBS Group Has Lowered Expectations for Acadia Healthcare (NASDAQ:ACHC) Stock Price

Key Points

• UBS Group has significantly reduced its price target for Acadia Healthcare from $45.00 to $31.00 while maintaining a "buy" rating, reflecting a potential upside of 69.87% from the current trading price.
• Acadia Healthcare's stock increased by 1.4% to $18.25 amid a higher volume of trade, with a market cap of $1.68 billion and a P/E ratio of 12.12.
• Analyst ratings for Acadia Healthcare show a consensus of "Moderate Buy," with five analysts rating it as a hold and seven issuing buy ratings, amidst price target adjustments from various firms.

Acadia Healthcare (NASDAQ:ACHC - Free Report) had its price objective trimmed by UBS Group from $45.00 to $31.00 in a report released on Thursday,Benzinga reports. The firm currently has a buy rating on the stock.

Several other equities research analysts also recently issued reports on the company. KeyCorp dropped their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Barclays dropped their target price on Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating on the stock in a research report on Thursday. Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Sunday, August 3rd. Stephens upgraded Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. Finally, Mizuho lowered their price objective on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. Five equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $44.75.

Acadia Healthcare Stock Performance

Acadia Healthcare stock traded down $0.17 during trading on Thursday, hitting $19.07. The stock had a trading volume of 3,114,766 shares, compared to its average volume of 2,065,977. Acadia Healthcare has a 1 year low of $17.13 and a 1 year high of $82.40. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. The stock's 50 day moving average is $22.13 and its two-hundred day moving average is $27.47. The stock has a market cap of $1.76 billion, a price-to-earnings ratio of 12.63, a price-to-earnings-growth ratio of 3.74 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, beating the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%. The business had revenue of $869.23 million for the quarter, compared to the consensus estimate of $839.59 million. During the same quarter in the prior year, the business earned $0.91 earnings per share. Acadia Healthcare's revenue for the quarter was up 9.2% on a year-over-year basis. As a group, analysts predict that Acadia Healthcare will post 3.38 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in ACHC. FMR LLC raised its stake in shares of Acadia Healthcare by 257.9% in the 4th quarter. FMR LLC now owns 6,230,631 shares of the company's stock valued at $247,045,000 after acquiring an additional 4,489,681 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Acadia Healthcare by 18.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company's stock valued at $126,189,000 after acquiring an additional 486,395 shares during the period. Hawk Ridge Capital Management LP increased its stake in Acadia Healthcare by 437.5% during the 1st quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company's stock worth $74,988,000 after buying an additional 2,013,126 shares during the period. Citigroup Inc. increased its stake in Acadia Healthcare by 5,144.2% during the 1st quarter. Citigroup Inc. now owns 2,376,209 shares of the company's stock worth $72,047,000 after buying an additional 2,330,898 shares during the period. Finally, Maverick Capital Ltd. increased its stake in Acadia Healthcare by 116.3% during the 1st quarter. Maverick Capital Ltd. now owns 2,246,923 shares of the company's stock worth $68,127,000 after buying an additional 1,208,296 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.